Clinical Trials Directory

Trials / Completed

CompletedNCT00229528

Effect of Paroxetine on COAT-Platelet Production in Normal Volunteers and Patients With Cardiovascular Disease

Dose Ranging Study of the Effect of Paroxetine on COAT-Platelet Production in Normal Volunteers and Patients With Cardiovascular Disease

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
25 (planned)
Sponsor
University of Oklahoma · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

COAT-platelets stands for collagen and thrombin stimulated platelets, which are two things in the body that make platelets stick together. These platelets may be important in the initiation of a heart attack (myocardial infarction). A chemical in the body called serotonin maybe responsible for COAT-platelet production. Paroxetine causes a significant reduction in platelet serotonin and therefore may have value in preventing heart attacks. Therefore, the current study is designed to determine whether paroxetine will decrease COAT-platelet production in normal volunteers and patients with cardiovascular disease.

Conditions

Interventions

TypeNameDescription
DRUGPaxil-CR

Timeline

Start date
2004-03-01
Primary completion
2006-05-01
Completion
2006-05-01
First posted
2005-09-29
Last updated
2008-09-22

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00229528. Inclusion in this directory is not an endorsement.